Učitavanje...
Bisphosphonate therapy for osteogenesis imperfecta
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and reduce these fractures in people...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2016
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611487/ https://ncbi.nlm.nih.gov/pubmed/27760454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005088.pub4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|